LETSimmun
Lymphocyte Engineering for Therapeutic Synthetic Immunity
Adoptive T cell therapy has advanced to become a distinguished and rapidly evolving translational research field in modern medicine. This collaborative research center (CRC) transregio (TRR) LETSIMMUN is setting out to become a hot spot for cutting-edge basic and translation research in Lymphocyte Engineering in Germany, and aspires to deliver novel concepts and cell products for clinical development that provide Therapeutic Synthetic Immunity for patients.
Events
ECS Training Group
The ECS Training Group supports the education of young scientistsin the field of lymphocyte engineering. More
Gender and Diversity Measures
LETSimmun is committed to improving the gender and diversity gap in science and taking actions against any form of disadvantages and discrimination. More
Play Video
CAR-T cells at work: in vivo imaging of CAR T cells in Primary CNS Lymphoma
INSTITUTIONS
